Arcus Biosciences (RCUS) Other Working Capital Changes (2017 - 2025)
Historic Other Working Capital Changes for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to -$26.0 million.
- Arcus Biosciences' Other Working Capital Changes fell 13880.6% to -$26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$256.0 million, marking a year-over-year decrease of 72580.65%. This contributed to the annual value of -$56.0 million for FY2024, which is 1764.71% up from last year.
- Arcus Biosciences' Other Working Capital Changes amounted to -$26.0 million in Q3 2025, which was down 13880.6% from -$160.0 million recorded in Q2 2025.
- In the past 5 years, Arcus Biosciences' Other Working Capital Changes registered a high of $67.0 million during Q3 2024, and its lowest value of -$339.6 million during Q4 2021.
- Moreover, its 5-year median value for Other Working Capital Changes was -$27.0 million (2022), whereas its average is -$43.1 million.
- Per our database at Business Quant, Arcus Biosciences' Other Working Capital Changes crashed by 30884272.73% in 2021 and then skyrocketed by 30937.5% in 2024.
- Over the past 5 years, Arcus Biosciences' Other Working Capital Changes (Quarter) stood at -$339.6 million in 2021, then skyrocketed by 89.99% to -$34.0 million in 2022, then surged by 50.0% to -$17.0 million in 2023, then tumbled by 147.06% to -$42.0 million in 2024, then surged by 38.1% to -$26.0 million in 2025.
- Its last three reported values are -$26.0 million in Q3 2025, -$160.0 million for Q2 2025, and -$28.0 million during Q1 2025.